Clinical trialNCT02011321WithdrawnPhase 2Interventional

Clevidipine for Vasospasm After Subarachnoid Hemorrhage (SAH)

SponsorHenry Ford Health SystemEnrollment0Cerebral AneurysmSubarachnoid HemorrhageVasospasm, Intracranial

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Vasospasm occurs frequently after aneurysmal subarachnoid hemorrhage and can lead to strokes. The investigators will investigate if infusion of a novel drug, clevidipine, will decrease vasospasm during the infusion and post infusion period using transcranial doppler monitoring of patients with subarachnoid hemorrhage and moderate severity vasospasm

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Mohammed Rehman, DO
Henry Ford Health System
Study Director
clinicaltrials.gov ↗
Panayiots Varelas, MD, PhD
Henry Ford Health System
Principal Investigator
clinicaltrials.gov ↗
Tamer Abdelhak, MD
Henry Ford Health System
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Henry Ford Hospital
Detroit, Michigan, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Clevidipine →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Mar 2014
Primary completion: 31 Mar 2018
Completion: 30 Sept 2018
Last update posted: 1 Feb 2023
Registered enrollment: 0
Registry id: NCT02011321

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.